However, the upregulation of autophagy by ERBB2 expression in cancer may provide a therapeutic window for cancer where autophagy can be targeted as it is demonstrated in this study that ERBB2 antibody inhibited autophagy to sensitize ERBB2-positive breast cancers to chemotherapy drugs. The gene discussed is ERBB2; the disease is cancer.